Farzin Hadizadeh
Overview
Explore the profile of Farzin Hadizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
965
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nejabat M, Hadizadeh F, Almahmeed W, Sahebkar A
Drug Discov Today
. 2025 Feb;
30(3):104316.
PMID: 39986645
Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have potential applications in cancer therapy and as cholesterol-lowering treatments. The impact of PCSK9 suppression on both tumor growth and metastasis, as well...
2.
Rassouli F, Matin M, Hadizadeh F, Nejabat M, Allahverdizadeh H, Jamali H, et al.
Front Pharmacol
. 2025 Feb;
16:1520881.
PMID: 39968177
Introduction: Colorectal cancer (CRC) is a prevalent malignancy worldwide with high mortality rate. Metastasis, the primary cause of cancer-related deaths, is attributed to various factors including tumor hypoxia. Due to...
3.
Tajik A, Mahdavizadeh V, Hadizadeh F, Shakour N
Curr Diabetes Rev
. 2025 Feb;
PMID: 39949094
Aims: This study aims to investigate the relationship between sarcopenia and circulating biomarkers in diabetes, with a focus on early detection and effective management strategies. Methods: A literature review was...
4.
Yousefian M, Hashemi M, Eskandarpour V, Zarghi A, Hadizadeh F, Ghodsi R
Bioorg Chem
. 2025 Feb;
156:108231.
PMID: 39904079
New series of indolin-2-ones possessing sunitinib scaffold and a hydroxamic acid moiety were designed and synthesized as inhibitors of HDAC, demonstrating significant anti-cancer properties with potential VEGFR inhibition, using sunitinib...
5.
Omidkhah N, Gheisari A, Oskuei S, Chamani J, Hadizadeh F, Atarodi A, et al.
Bioorg Chem
. 2025 Jan;
154:108098.
PMID: 39753040
In this study, novel 2-styrylquinoline derivatives possessing a planar aromatic system and a flexible side chain with an amino substituent were designed and synthesized as DNA-intercalating antitumor agents. The cytotoxic...
6.
Shakour N, Mahdinezhad M, Asgharzadeh F, Khazaei M, Simental-Mendia L, Roshan N, et al.
J Diabetes Complications
. 2024 Nov;
38(12):108897.
PMID: 39489911
Oxygen-free radicals have been implicated in the initiation of diabetic complications. Thiazolidinediones (TZDs), known for their antidiabetic properties, also demonstrate notable antioxidant and anti-inflammatory effects. Although a recently developed imidazolyl...
7.
Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F
Eur J Pharm Biopharm
. 2024 Oct;
206:114568.
PMID: 39472267
No abstract available.
8.
Shakour N, Mahdinezhad M, Hadjzadeh M, Sahebkar A, Hadizadeh F
J Mol Histol
. 2024 Oct;
55(6):1315-1325.
PMID: 39382759
Background: Diabetes mellitus represents a prominent global health concern, characterized by a rising prevalence rate. Type 2 Diabetes Mellitus (T2DM) is purported to be associated with an intricate interplay of...
9.
Nejabat M, Samie A, Khojastehnezhad A, Hadizadeh F, Ramezani M, Alibolandi M, et al.
ACS Appl Mater Interfaces
. 2024 Aug;
16(39):51837-51859.
PMID: 39163539
Chemotherapy as a common anticancer therapeutic modality is often challenged by various obstacles such as poor stability, low solubility, and severe side effects of chemotherapeutic agents as well as multidrug...
10.
Abdollahi Z, Nejabat M, Abnous K, Hadizadeh F
Res Pharm Sci
. 2024 Jul;
19(1):1-12.
PMID: 39006977
Background And Purpose: Alzheimer's disease (AD) is a common neurodegenerative disease and the fifth leading cause of death among the elderly. The development of drugs for AD treatment is based...